There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...
In the univariate analysis, those on an SGLT-2i/GLP-1 RA had a reduced risk for mortality, incident MI, and composite.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback